Global Health Innovative Technology Fund donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Websitehttps://www.ghitfund.org/
Wikipedia pagehttps://en.wikipedia.org/wiki/Global_Health_Innovative_Technology_Fund_(GHIT)

Donation amounts by donor and year for donee Global Health Innovative Technology Fund

Donor Total 2017 2016 2015 2014 2013
Bill and Melinda Gates Foundation (filter this donee) 70,910,000.00 1,000,000.00 42,200,000.00 6,000,000.00 4,400,000.00 17,310,000.00
Wellcome Trust (filter this donee) 3,000,000.00 0.00 0.00 3,000,000.00 0.00 0.00
Total 73,910,000.00 1,000,000.00 42,200,000.00 9,000,000.00 4,400,000.00 17,310,000.00

Full list of donations in reverse chronological order (30 donations)

DonorAmount (current USD)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation500,000.002017-09-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation250,000.002017-09-15Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation250,000.002017-09-15Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation10,000,000.002016-11-02Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation10,000,000.002016-11-02Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation10,000,000.002016-11-02Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation10,000,000.002016-11-02Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,100,000.002016-02-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002016-02-24Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002016-02-24Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,500,000.002015-10-23Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,500,000.002015-10-23Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,500,000.002015-10-23Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,500,000.002015-10-23Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Wellcome Trust3,000,000.002015-03-13FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- The Wellcome Trust has entered into a new partnership with the Japanese Global Health Innovative Technology Fund (GHIT Fund) – a collaboration that will help support the development of new tools to tackle infectious diseases that devastate the world’s poorest people. Affected regions: International; affected countries: Japan.
Bill and Melinda Gates Foundation550,000.002014-11-19Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002014-11-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002014-11-19Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002014-11-19Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,100,000.002014-11-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002014-11-19Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002014-11-19Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,100,000.002013-10-29Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002013-10-29Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation550,000.002013-10-29Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop new drugs for the prevention and treatment of malaria, tuberculosis, Chagas, and visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,750,000.002013-06-05Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,750,000.002013-06-05Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,750,000.002013-06-05Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,750,000.002013-06-05Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop new health technologies as a result of funding and development collaborations with Japanese industry and government; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation110,000.002013-02-25Information and communication technology (ICT)https://iatiregistry.org/publisher/bmgf-- to support the systems and documentation needed for the launch of the GHIT Fund. Global Health Innovative Technology Fund (G-HIT Fund). Investment start date: 2/25/2013 to end date: 4/30/2013. Grantee name: Global Health Innovative Technology Fund; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.